Meet Kaleb
When Kaleb was referred to St. Jude for treatment of a blood disorder, he and his family found hope despite the challenges they faced.
St. Jude patient Kaleb
St Jude patient Kaleb with his mom
Kaleb's story
When Kaleb began to walk, his mom, Jerhonda, made sure he took his first steps in his playpen. When he had enough balance, she let him try his steps on the harder floor.
Jerhonda must be extra careful with Kaleb, her middle child, because one fall can mean a major bruise.
As a baby, Kaleb was diagnosed with chronic immune thrombocytopenia (ITP), an autoimmune disorder, a condition where the immune system destroys platelets, resulting in very low numbers of platelets in the blood. Platelets are blood cells that help stop bleeding. ITP can cause easy bruising and bleeding. Jerhonda had never heard of the blood disorder.
“It was scary,” she said.
St. Jude patient Kaleb with his dad
Doctors referred Kaleb to St. Jude Children’s Research Hospital. She was relieved to hear that families never receive a bill from St. Jude for treatment, travel, housing or food.
I was overjoyed that my son could receive treatment and I didn’t have to worry about [the medical expenses].
- Jerhonda, Kaleb's mom
Families never receive a bill from St. Jude for treatment, travel, housing or food — so they can focus on helping their child live.
Jerhonda described Kaleb as playful, smart, independent and curious. He also loves to run, play basketball and cuddle with his mother, and enjoys music and humming along to songs.
St. Jude patient Kaleb with his parents
St. Jude won't stop until no child — anywhere — dies from cancer.
You might also be interested in ...
-
Read about more St. Jude patients
Be inspired by the touching stories of St. Jude patients facing childhood cancer and other diseases.
-
Find ways to get involved
Learn about all the ways you can get involved with St. Jude and help support our lifesaving mission.
-
Our unique operating model
There are great research institutions, great hospitals and great charities — we’re all three. See how we’re funded, how our operating model works and our plans for the future.